检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:高冰芳[1] 杨悦[1] 杨京京[2] 何丽馥[2] 李敬岩[2] 陈素贤[2] 万义增[2]
机构地区:[1]辽宁医学院病理学教研室 [2]辽宁医学院附属第三医院病理科,辽宁锦州121001
出 处:《辽宁医学院学报》2011年第1期9-12,95,共5页Journal of Liaoning Medical University (LNMU) Bimonthly
摘 要:目的探讨Dnmt1和Caveolin-1在结直肠癌中的表达及其临床病理意义。方法应用免疫组化PV-9000二步法检测84例结直肠癌组织及20例癌旁正常组织中Dnmt1、Caveolin-1蛋白的表达情况,分析二者与其临床病理特征的关系。结果 Dnmt1蛋白在结直肠癌中的阳性表达率(72.62%)显著高于癌旁正常组织(25.00%)(P<0.05);Caveolin-1蛋白在结直肠癌中的阳性表达率(32.14%)显著低于癌旁正常组织表达率(75.00%)(P<0.05);二者表达与肿瘤的组织学分化程度、Dukes分期、浸润深度、淋巴结转移等组间差异性有显著性意义(P<0.05);Dnmt1和Caveolin-1蛋白的表达呈负相关关系(r=-0.304,P=0.000)。结论 Dnmt1和Caveolin-1的表达与结直肠癌的发生、发展密切相关。Objective To investigate the expressions and their clinicopathological significance of Dnmtl and Caveolin - 1 proteins in coloreetal cancer. Methods The expressions of Dnmtl and Caveolin - 1 in 84 cases of colorectal carcinomas and 20 cases of adjacent normal mucosa were detected by PV - 9000 two - step immunohistochemical method. The relationship between their expressions and the clinicopathologic features of colorectal cancers were analyzed. Results The positive rate of Dnmtl in colorectal carcinomas (72. 62% ) was significantly higher than that in normal tissues (25.00%) (P 〈0. 05). The positive rate of Caveolin - 1 in colorectal carcinomas (32. 14% ) was significantly lower than that in noral control tissues (75.00%) (P 〈 0. 05). Both the expressions of Dnmtl and Caveolin - 1 were associated with histologi- cal differentiation, serous membrane invasion, lymph node metastasis and Dukes stage of colorectal carcinoma (P 〈 0. 05). The expression of Dnmtl was negatively correlated with that of Caveolin - 1 ( r = - 0. 304, P = 0. 000). Conclusions The expressions of Dnmtl and Caveolin - 1 are closely related to carcinogenesis and the development of colorectal carcinonlas.
关 键 词:结直肠癌 DNMT1 CAVEOLIN-1 免疫组织化学
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3